Effectiveness of the ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis.
Ontology highlight
ABSTRACT: Hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) are transmitted to humans through infection with the old- and new-world hantaviruses, respectively. Together these diseases affect tens of thousands of people every year, and no specific treatment is available. To investigate whether ribavirin treatment for hantaviruses infections decreases disease severity, we conducted a meta-analysis involving human and animal studies. After defining the research protocol and criteria for inclusion/exclusion, we identified seven studies. We found that in groups with HPS who were treated with ribavirin, there was no significant reduction in mortality (RR 0.99, 95 % CI 0.60-1.61, I(2) = 0 %). On the other hand, for animal group with HPS-like disease, there was significant
SUBMITTER: Moreli ML
PROVIDER: S-EPMC4188213 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA